DLBS Products

DLBS Products
Product Description

Beyond Botanicals : DLBS Innovation in Evidence-Based Herbal Medicine
A relaxed evening where you can connect with our team and fellow partners over drinks and light bites, which relate to Herbal Medicine.
Event Details:
 Date : Tue, 28 Oct 2025
Time : 6.00 – 7.30 PM
Location : Westin Hotel, Frankfurt – Paris Room
Konrad-Adenauer-Straβe 7, 60313 Frankfurt am Main

RSPV : [email protected] | +62 812.9604.2607

Read more Show less

Dexa Medica

  • Country/Region:
    Indonesia
  • On CPHI since:
    2020
  • Certificates:
    3
  • Employees:
    5000+
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less

Dexa Medica

  • Country/Region:
    Indonesia
  • On CPHI since:
    2020
  • Certificates:
    3
  • Employees:
    5000+
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile

More Products from Dexa Medica (15)

  • Dexa Group - Full Product List

    Product Dexa Group - Full Product List

    https://www.dexagroup.com/products/ This includes are generics, natural medicines and VMS
  • Bendamustine 25, 100

    Product Bendamustine 25, 100

    PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Bendamustine 25 mg and 100 mg. Indication : Chronic lymphocytic Leukemia, Non-Hodgin Lymphoma and Multiple Myeloma. Contact us for more information
  • Bortezomib 1, 3.5

    Product Bortezomib 1, 3.5

    PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Bortezomib 1 mg, 3.5 mg Indication : multiple myeloma, mantle cell lymphoma. Contact us for more information
  • Carboplatin 150, 450

    Product Carboplatin 150, 450

    PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Carboplatin 150 mg, 450 mg. Indication : Initial treatment of advance ovarian carcinoma, Secondary treatment of advance ovarian carcinoma. Contact us for more information
  • Cisplatin 10, 50

    Product Cisplatin 10, 50

    PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Cisplatin 10 mg, 50 mg. Indication : Metastatic testicular tumors or metastatic ovarian tumors and advanced bladder cancer. Contact us for more information
  • Cyclophosphamide 200, 500, 1000

    Product Cyclophosphamide 200, 500, 1000

    PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Cyclophosphamide 200 mg, 500 mg and 1000 mg. Indication :  Leukemia, lymphogranulomatosis, lymphosarcoma, retinothelial sarcoma, multiple myeloma, Breast Cancer, Ovarian Cancer. Contact us for more i...
  • Docetaxel 20, 80

    Product Docetaxel 20, 80

    PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Docetaxel 20 mg, 80 mg. Indication : Breast cancer, Non-small cell lung cancer, Prostate cancer, Head and neck cancer, Ovarian cancer, Gastric adenocarcinoma. Contact us for more information
  • Epirubicin 10, 50

    Product Epirubicin 10, 50

    PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Epirubicin 10 mg, 50 mg. Indication :  Breast carcinoma, Ovarian carcinoma, Small cell lung cancer, Non-smell cell lung cancer, Gastric carcinoma, Transitional cell cancer of the bladder, Soft tissue...
  • Fluorouracil 500

    Product Fluorouracil 500

    PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Fluorouracil 500 mg. Indication :Colon Carcinoma, Rectum, Breast, Stomach, Pancreas. Contact us for more information
  • Gemcitabine 200, 1000

    Product Gemcitabine 200, 1000

    PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Gemcitabine 200 mg, 1000 mg. Indication :  Locally advance or metastatic bladder cancer, metastatic adenocarcinoma of the pancreas, advanced or metastatic non-small cell lung cancer (NSCLC), locally ...
  • Oxaliplatin 50, 100

    Product Oxaliplatin 50, 100

    PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Oxaliplatin 50 mg. Indication : Stage III colon cancer (Duke's C) and metastatic colorectal cancer. Contact us for more information    
  • Paclitaxel 30, 100, 300

    Product Paclitaxel 30, 100, 300

    PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Paclitaxel 30 mg, 100 mg and 300 mg. Indication : Ovarian carcinoma, Breast carcinoma, Advanced non-small cell lung carcinoma, AIDS-related Kaposi's sarcoma. Contact us for more information
show all 15 other products

Dexa Medica resources (1)